English

WaferGen Bio-systems, Inc.

EDGAR

Quarterly report (10-Q) · filed 2016-11-10

57 filing records in this dataset, filed from 2006-10-26 to 2016-11-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.39 million USD

2016 Q3 · USD

Exact inputs and evidence

Revenue: 2394000 USD Source

Operating margin

-148.96%

2016 Q3 · %

Exact inputs and evidence

Operating Income: -3566000 USD Source
Revenue: 2394000 USD Source

Operating cash flow

-2.12 million USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -9613000 USD Source
Operating Cash Flow: -7496000 USD Source

Free cash flow

-2.16 million USD

2016 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -9613000 USD Source
Operating Cash Flow: -7496000 USD Source
Capital Expenditure: 299000 USD Source
Capital Expenditure: 258000 USD Source

Cash and cash equivalents: 5.15 million USD 2016-09-30 Source
Exact value

5147000 USD
Long-term debt including current maturities: 3.39 million USD 2012-12-31 Source
Exact value

3393159 USD
Shares outstanding: 19.3 million shares 2016-09-30 Source
Exact value

19317000 shares

Reported share-count change

214.61% · 13.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6140000 shares · 2015-09-30· Source
19317000 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

9.24 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Revenue: 2401000 USD · 2015-10-01 – 2015-12-31 Source
Revenue: 1930000 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 2517000 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 2394000 USD · 2016-07-01 – 2016-09-30 Source

Net income

-16.2 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -3212000 USD · 2015-10-01 – 2015-12-31 Source
Net income: -4408000 USD · 2016-01-01 – 2016-03-31 Source
Net income: -4887000 USD · 2016-04-01 – 2016-06-30 Source
Net income: -3670000 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-13.5 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -14638000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -10712000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -4152000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -7496000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -4152000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -9613000 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -7496000 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

461 thousand USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Capital expenditure: 308000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 146000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 157000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 258000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 157000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 299000 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 258000 USD · 2016-01-01 – 2016-06-30 Source

Free cash flow

-14 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -14638000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -10712000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -4152000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -7496000 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -4152000 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -9613000 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -7496000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 308000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 146000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 157000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 258000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 157000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 299000 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 258000 USD · 2016-01-01 – 2016-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-11-10.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2015-12-31
Operating income: 11 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 11 of 11 periods available· newest 2015-12-31
Capital expenditure: 11 of 11 periods available· newest 2015-12-31
Total assets: 10 of 11 periods available· newest 2015-12-31
Total liabilities: 6 of 11 periods available· newest 2015-12-31
Current assets: 10 of 11 periods available· newest 2015-12-31
Current liabilities: 10 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2012-12-31
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.4%

Prior period

USD 6 million

2014-01-01 – 2014-12-31
Current period

USD 7.17 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

7167000 − 6001000 = 1166000 USD

6001000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
7167000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Year-over-year change in Revenue: 1166000 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7167000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#258988 Filing: 000136899316000086 Input fundies:Revenue: 6001000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#257606 Filing: 000136899316000086
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.62 million

Prior period

−USD 10.69 million

2014-01-01 – 2014-12-31
Current period

−USD 15.32 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-15315000 − -10693000 = -4622000 USD

-10693000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-15315000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Year-over-year change in Net income: -4622000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -15315000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#227629 Filing: 000136899316000086 Input fundies:NetIncome: -10693000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#226640 Filing: 000136899316000086
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 4.35 million

Prior period

−USD 10.29 million

2014-01-01 – 2014-12-31
Current period

−USD 14.64 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-14638000 − -10288000 = -4350000 USD

-10288000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-14638000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Year-over-year change in Operating cash flow: -4350000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14638000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225816 Filing: 000136899316000086 Input fundies:OperatingCashFlow: -10288000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225604 Filing: 000136899316000086
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-8.1%

Prior period

USD 335,000

2014-01-01 – 2014-12-31
Current period

USD 308,000

2015-01-01 – 2015-12-31

Exact inputs and evidence

308000 − 335000 = -27000 USD

335000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
308000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Year-over-year change in Capital expenditure: -27000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 308000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240647 Filing: 000136899316000086 Input fundies:CapitalExpenditure: 335000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240438 Filing: 000136899316000086
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 7.17 million 100% of revenue
Cost of revenue USD 3.22 million 45% of revenue
Operating expenses USD 19.04 million 266% of revenue
Operating income −USD 15.09 million −211% of revenue
Tax, interest and other Derived USD 223,000 3.1% of revenue
Net income −USD 15.32 million −214% of revenue

Cash

Operating cash flow −USD 14.64 million −204% of revenue
Capital expenditure USD 308,000 4.3% of revenue
Free cash flow Derived −USD 14.95 million −209% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 2,690% of revenue.
2008 Operating loss: operating costs were 1,391% of revenue.
2009 Operating loss: operating costs were 1,391% of revenue.
2009 Operating loss: operating costs were 2,739% of revenue.
2010 Operating loss: operating costs were 2,739% of revenue.
2011 Operating loss: operating costs were 3,677% of revenue.
2012 Operating loss: operating costs were 1,766% of revenue.
2013 Operating loss: operating costs were 860% of revenue.
2014 Operating loss: operating costs were 307% of revenue.
2015 Operating loss: operating costs were 311% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2007-03-19 – 2008-03-18	228973	6160145 Derived	-5931172	26492 Derived	-5957664	-4941952 Derived	Source 2007-03-19 – 2008-03-18: 228973 USD Inspect Revenue Open source 2007-03-19 – 2008-03-18: -5931172 USD Inspect Operating Income Open source 2007-03-19 – 2008-03-18: -5957664 USD Inspect Net Income Open source 2007-03-19 – 2008-03-18: -4737175 USD Inspect Operating Cash Flow Open source 2007-03-19 – 2008-03-18: 204777 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	621866	8652266 Derived	-8030400	11037 Derived	-8041437	-7886077 Derived	Source 2008-01-01 – 2008-12-31: 621866 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -8030400 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -8041437 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -7284180 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 601897 USD Inspect Capital Expenditure Open source
2009 2008-03-19 – 2009-03-18	621866	8652266 Derived	-8030400	11037 Derived	-8041437	-7886077 Derived	Source 2008-03-19 – 2009-03-18: 621866 USD Inspect Revenue Open source 2008-03-19 – 2009-03-18: -8030400 USD Inspect Operating Income Open source 2008-03-19 – 2009-03-18: -8041437 USD Inspect Net Income Open source 2008-03-19 – 2009-03-18: -7284180 USD Inspect Operating Cash Flow Open source 2008-03-19 – 2009-03-18: 601897 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	379373	10389451 Derived	-10010078	610410 Derived	-10620488	-8095623 Derived	Source 2009-01-01 – 2009-12-31: 379373 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -10010078 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -10620488 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -7832332 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 263291 USD Inspect Capital Expenditure Open source
2010 2009-03-16 – 2010-03-15	379373	10389451 Derived	-10010078	19884634 Derived	-29894712	-25538686 Derived	Source 2009-03-16 – 2010-03-15: 379373 USD Inspect Revenue Open source 2009-03-16 – 2010-03-15: -10010078 USD Inspect Operating Income Open source 2009-03-16 – 2010-03-15: -29894712 USD Inspect Net Income Open source 2009-03-16 – 2010-03-15: -24299370 USD Inspect Operating Cash Flow Open source 2009-03-16 – 2010-03-15: 1239316 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	522931	19225771 Derived	-18702840	-5557762 Derived	-13145078	-17248004 Derived	Source 2011-01-01 – 2011-12-31: 522931 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -18702840 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -13145078 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -16626884 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 621120 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	586176	10352152 Derived	-9765976	-1589314 Derived	-8176662	-8922655 Derived	Source 2012-01-01 – 2012-12-31: 586176 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -9765976 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -8176662 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -8867888 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 54767 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	1304747	11227190 Derived	-9922443	6343829 Derived	-16266272	-8312759 Derived	Source 2013-01-01 – 2013-12-31: 1304747 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -9922443 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -16266272 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -8221214 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 91545 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	6001000	18451000 Derived	-12450000	-1757000 Derived	-10693000	-10623000 Derived	Source 2014-01-01 – 2014-12-31: 6001000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -12450000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -10693000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -10288000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 335000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	7167000	22259000 Derived	-15092000	223000 Derived	-15315000	-14946000 Derived	Source 2015-01-01 – 2015-12-31: 7167000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -15092000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -15315000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -14638000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 308000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.2M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-03-18	Revenue	228973	Revenue: 228973 Open source
20082008-12-31	Revenue	621866	Revenue: 621866 Open source
20092009-03-18	Revenue	621866	Revenue: 621866 Open source
20092009-12-31	Revenue	379373	Revenue: 379373 Open source
20102010-03-15	Revenue	379373	Revenue: 379373 Open source
20112011-12-31	Revenue	522931	Revenue: 522931 Open source
20122012-12-31	Revenue	586176	Revenue: 586176 Open source
20132013-12-31	Revenue	1304747	Revenue: 1304747 Open source
20142014-12-31	Revenue	6001000	Revenue: 6001000 Open source
20152015-12-31	Revenue	7167000	Revenue: 7167000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.4% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-03-18	Year over year	No prior comparable period	Revenue: 228973 Open source
20082008-12-31	Year over year	171.6%	Revenue: 621866 Open source Revenue: 228973 Open source
20092009-03-18	Year over year	171.6%	Revenue: 621866 Open source Revenue: 228973 Open source
20092009-12-31	Year over year	-39%	Revenue: 379373 Open source Revenue: 621866 Open source
20102010-03-15	Year over year	-39%	Revenue: 379373 Open source Revenue: 621866 Open source
20112011-12-31	Year over year	No prior comparable period	Revenue: 522931 Open source
20122012-12-31	Year over year	12.1%	Revenue: 586176 Open source Revenue: 522931 Open source
20132013-12-31	Year over year	122.6%	Revenue: 1304747 Open source Revenue: 586176 Open source
20142014-12-31	Year over year	359.9%	Revenue: 6001000 Open source Revenue: 1304747 Open source
20152015-12-31	Year over year	19.4%	Revenue: 7167000 Open source Revenue: 6001000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -210.6% 2015

Net margin -213.7% 2015

Free cash flow margin -208.5% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-03-18	Operating margin	-2,590.3%	Operating Income: -5931172 Open source Revenue: 228973 Open source
20082008-12-31	Operating margin	-1,291.3%	Operating Income: -8030400 Open source Revenue: 621866 Open source
20092009-03-18	Operating margin	-1,291.3%	Operating Income: -8030400 Open source Revenue: 621866 Open source
20092009-12-31	Operating margin	-2,638.6%	Operating Income: -10010078 Open source Revenue: 379373 Open source
20102010-03-15	Operating margin	-2,638.6%	Operating Income: -10010078 Open source Revenue: 379373 Open source
20112011-12-31	Operating margin	-3,576.5%	Operating Income: -18702840 Open source Revenue: 522931 Open source
20122012-12-31	Operating margin	-1,666%	Operating Income: -9765976 Open source Revenue: 586176 Open source
20132013-12-31	Operating margin	-760.5%	Operating Income: -9922443 Open source Revenue: 1304747 Open source
20142014-12-31	Operating margin	-207.5%	Operating Income: -12450000 Open source Revenue: 6001000 Open source
20152015-12-31	Operating margin	-210.6%	Operating Income: -15092000 Open source Revenue: 7167000 Open source
20082008-03-18	Net margin	-2,601.9%	Net Income: -5957664 Open source Revenue: 228973 Open source
20082008-12-31	Net margin	-1,293.1%	Net Income: -8041437 Open source Revenue: 621866 Open source
20092009-03-18	Net margin	-1,293.1%	Net Income: -8041437 Open source Revenue: 621866 Open source
20092009-12-31	Net margin	-2,799.5%	Net Income: -10620488 Open source Revenue: 379373 Open source
20102010-03-15	Net margin	-7,880%	Net Income: -29894712 Open source Revenue: 379373 Open source
20112011-12-31	Net margin	-2,513.7%	Net Income: -13145078 Open source Revenue: 522931 Open source
20122012-12-31	Net margin	-1,394.9%	Net Income: -8176662 Open source Revenue: 586176 Open source
20132013-12-31	Net margin	-1,246.7%	Net Income: -16266272 Open source Revenue: 1304747 Open source
20142014-12-31	Net margin	-178.2%	Net Income: -10693000 Open source Revenue: 6001000 Open source
20152015-12-31	Net margin	-213.7%	Net Income: -15315000 Open source Revenue: 7167000 Open source
20082008-03-18	Free cash flow margin	-2,158.3%	Revenue: 228973 Open source Operating Cash Flow: -4737175 Open source Capital Expenditure: 204777 Open source
20082008-12-31	Free cash flow margin	-1,268.1%	Revenue: 621866 Open source Operating Cash Flow: -7284180 Open source Capital Expenditure: 601897 Open source
20092009-03-18	Free cash flow margin	-1,268.1%	Revenue: 621866 Open source Operating Cash Flow: -7284180 Open source Capital Expenditure: 601897 Open source
20092009-12-31	Free cash flow margin	-2,133.9%	Revenue: 379373 Open source Operating Cash Flow: -7832332 Open source Capital Expenditure: 263291 Open source
20102010-03-15	Free cash flow margin	-6,731.8%	Revenue: 379373 Open source Operating Cash Flow: -24299370 Open source Capital Expenditure: 1239316 Open source
20112011-12-31	Free cash flow margin	-3,298.3%	Revenue: 522931 Open source Operating Cash Flow: -16626884 Open source Capital Expenditure: 621120 Open source
20122012-12-31	Free cash flow margin	-1,522.2%	Revenue: 586176 Open source Operating Cash Flow: -8867888 Open source Capital Expenditure: 54767 Open source
20132013-12-31	Free cash flow margin	-637.1%	Revenue: 1304747 Open source Operating Cash Flow: -8221214 Open source Capital Expenditure: 91545 Open source
20142014-12-31	Free cash flow margin	-177%	Revenue: 6001000 Open source Operating Cash Flow: -10288000 Open source Capital Expenditure: 335000 Open source
20152015-12-31	Free cash flow margin	-208.5%	Revenue: 7167000 Open source Operating Cash Flow: -14638000 Open source Capital Expenditure: 308000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.6M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-03-18	Operating cash flow	-4737175	Operating Cash Flow: -4737175 Open source
20082008-12-31	Operating cash flow	-7284180	Operating Cash Flow: -7284180 Open source
20092009-03-18	Operating cash flow	-7284180	Operating Cash Flow: -7284180 Open source
20092009-12-31	Operating cash flow	-7832332	Operating Cash Flow: -7832332 Open source
20102010-03-15	Operating cash flow	-24299370	Operating Cash Flow: -24299370 Open source
20112011-12-31	Operating cash flow	-16626884	Operating Cash Flow: -16626884 Open source
20122012-12-31	Operating cash flow	-8867888	Operating Cash Flow: -8867888 Open source
20132013-12-31	Operating cash flow	-8221214	Operating Cash Flow: -8221214 Open source
20142014-12-31	Operating cash flow	-10288000	Operating Cash Flow: -10288000 Open source
20152015-12-31	Operating cash flow	-14638000	Operating Cash Flow: -14638000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.9M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-03-18	Free cash flow	-4941952	Operating Cash Flow: -4737175 Open source Capital Expenditure: 204777 Open source
20082008-12-31	Free cash flow	-7886077	Operating Cash Flow: -7284180 Open source Capital Expenditure: 601897 Open source
20092009-03-18	Free cash flow	-7886077	Operating Cash Flow: -7284180 Open source Capital Expenditure: 601897 Open source
20092009-12-31	Free cash flow	-8095623	Operating Cash Flow: -7832332 Open source Capital Expenditure: 263291 Open source
20102010-03-15	Free cash flow	-25538686	Operating Cash Flow: -24299370 Open source Capital Expenditure: 1239316 Open source
20112011-12-31	Free cash flow	-17248004	Operating Cash Flow: -16626884 Open source Capital Expenditure: 621120 Open source
20122012-12-31	Free cash flow	-8922655	Operating Cash Flow: -8867888 Open source Capital Expenditure: 54767 Open source
20132013-12-31	Free cash flow	-8312759	Operating Cash Flow: -8221214 Open source Capital Expenditure: 91545 Open source
20142014-12-31	Free cash flow	-10623000	Operating Cash Flow: -10288000 Open source Capital Expenditure: 335000 Open source
20152015-12-31	Free cash flow	-14946000	Operating Cash Flow: -14638000 Open source Capital Expenditure: 308000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

31.4% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-03-18	Liabilities / assets	Not reported	No source recorded
2008-12-31	Liabilities / assets	Not reported	Total Assets: 3812100 Open source
2009-03-18	Liabilities / assets	Not reported	Total Assets: 3812100 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 6891154 Open source
2010-03-15	Liabilities / assets	Not reported	Total Assets: 6891154 Open source
20112011-12-31	Liabilities / assets	50.8%	Total Liabilities: 9474707 Open source Total Assets: 18643883 Open source
20122012-12-31	Liabilities / assets	82.9%	Total Liabilities: 7374996 Open source Total Assets: 8897458 Open source
20132013-12-31	Liabilities / assets	110.1%	Total Liabilities: 13244724 Open source Total Assets: 12030929 Open source
20142014-12-31	Liabilities / assets	32%	Total Liabilities: 6627000 Open source Total Assets: 20707000 Open source
20152015-12-31	Liabilities / assets	31.4%	Total Liabilities: 7176000 Open source Total Assets: 22873000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.59× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2008-03-18	Current assets / current liabilities	Not reported	No source recorded
20082008-12-31	Current assets / current liabilities	2.14×	Current Assets: 3001071 Open source Current Liabilities: 1405330 Open source
20092009-03-18	Current assets / current liabilities	2.14×	Current Assets: 3001071 Open source Current Liabilities: 1405330 Open source
20092009-12-31	Current assets / current liabilities	2.96×	Current Assets: 6391176 Open source Current Liabilities: 2161053 Open source
20102010-03-15	Current assets / current liabilities	2.96×	Current Assets: 6391176 Open source Current Liabilities: 2161053 Open source
20112011-12-31	Current assets / current liabilities	7.65×	Current Assets: 16077700 Open source Current Liabilities: 2101410 Open source
20122012-12-31	Current assets / current liabilities	4.1×	Current Assets: 7266565 Open source Current Liabilities: 1773653 Open source
20132013-12-31	Current assets / current liabilities	4.86×	Current Assets: 11719102 Open source Current Liabilities: 2413275 Open source
20142014-12-31	Current assets / current liabilities	4.55×	Current Assets: 17406000 Open source Current Liabilities: 3822000 Open source
20152015-12-31	Current assets / current liabilities	4.59×	Current Assets: 19839000 Open source Current Liabilities: 4326000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2007-03-19 – 2008-03-18	−USD 5.96 million Exact value Exact value: -5957664 USD 2007-03-19 – 2008-03-18: -5957664 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2008-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -5957664 USD Concept: fundies:NetIncome Period: 2007-03-19 to 2008-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2008-03-18&surface=latest&period_type=duration&start=2007-03-19&unit=USD&dimensions= Input fundies:NetIncome: -5957664 USD (2007-03-19 to 2008-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#17853 The citation records this snapshot. The page link may show a newer release later.	−USD 4.74 million Exact value Exact value: -4737175 USD 2007-03-19 – 2008-03-18: -4737175 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2008-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -4737175 USD Concept: fundies:OperatingCashFlow Period: 2007-03-19 to 2008-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-18&surface=latest&period_type=duration&start=2007-03-19&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4737175 USD (2007-03-19 to 2008-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18193 The citation records this snapshot. The page link may show a newer release later.	USD 204,777 Exact value Exact value: 204777 USD 2007-03-19 – 2008-03-18: 204777 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2008-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 204777 USD Concept: fundies:CapitalExpenditure Period: 2007-03-19 to 2008-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-18&surface=latest&period_type=duration&start=2007-03-19&unit=USD&dimensions= Input fundies:CapitalExpenditure: 204777 USD (2007-03-19 to 2008-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18263 The citation records this snapshot. The page link may show a newer release later.	−USD 4.94 million Calculation and evidence -4737175 − 204777 USD Exact free cash flow: -4941952 USD 2007-03-19 – 2008-03-18: -4737175 USD · Inspect Operating Cash Flow · Source 2007-03-19 – 2008-03-18: 204777 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2008-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -4941952 USD Concept: free-cash-flow Period: 2007-03-19 to 2008-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4737175 USD (2007-03-19 to 2008-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18193 Input fundies:CapitalExpenditure: 204777 USD (2007-03-19 to 2008-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18263 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 8.04 million Exact value Exact value: -8041437 USD 2008-01-01 – 2008-12-31: -8041437 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2008-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -8041437 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8041437 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000017.txt#10718 The citation records this snapshot. The page link may show a newer release later.	−USD 7.28 million Exact value Exact value: -7284180 USD 2008-01-01 – 2008-12-31: -7284180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2008-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -7284180 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7284180 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000017.txt#11102 The citation records this snapshot. The page link may show a newer release later.	USD 601,897 Exact value Exact value: 601897 USD 2008-01-01 – 2008-12-31: 601897 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2008-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 601897 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 601897 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000017.txt#11148 The citation records this snapshot. The page link may show a newer release later.	−USD 7.89 million Calculation and evidence -7284180 − 601897 USD Exact free cash flow: -7886077 USD 2008-01-01 – 2008-12-31: -7284180 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 601897 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2008-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -7886077 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7284180 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000017.txt#11102 Input fundies:CapitalExpenditure: 601897 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000017.txt#11148 The citation records this snapshot. The page link may show a newer release later.
2009 2008-03-19 – 2009-03-18	−USD 8.04 million Exact value Exact value: -8041437 USD 2008-03-19 – 2009-03-18: -8041437 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2009-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -8041437 USD Concept: fundies:NetIncome Period: 2008-03-19 to 2009-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2009-03-18&surface=latest&period_type=duration&start=2008-03-19&unit=USD&dimensions= Input fundies:NetIncome: -8041437 USD (2008-03-19 to 2009-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#6893 The citation records this snapshot. The page link may show a newer release later.	−USD 7.28 million Exact value Exact value: -7284180 USD 2008-03-19 – 2009-03-18: -7284180 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2009-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -7284180 USD Concept: fundies:OperatingCashFlow Period: 2008-03-19 to 2009-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-18&surface=latest&period_type=duration&start=2008-03-19&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7284180 USD (2008-03-19 to 2009-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18193 The citation records this snapshot. The page link may show a newer release later.	USD 601,897 Exact value Exact value: 601897 USD 2008-03-19 – 2009-03-18: 601897 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2009-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 601897 USD Concept: fundies:CapitalExpenditure Period: 2008-03-19 to 2009-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-18&surface=latest&period_type=duration&start=2008-03-19&unit=USD&dimensions= Input fundies:CapitalExpenditure: 601897 USD (2008-03-19 to 2009-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18263 The citation records this snapshot. The page link may show a newer release later.	−USD 7.89 million Calculation and evidence -7284180 − 601897 USD Exact free cash flow: -7886077 USD 2008-03-19 – 2009-03-18: -7284180 USD · Inspect Operating Cash Flow · Source 2008-03-19 – 2009-03-18: 601897 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2009-03-18 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -7886077 USD Concept: free-cash-flow Period: 2008-03-19 to 2009-03-18 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7284180 USD (2008-03-19 to 2009-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18193 Input fundies:CapitalExpenditure: 601897 USD (2008-03-19 to 2009-03-18) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-09-000009.txt#18263 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 10.62 million Exact value Exact value: -10620488 USD 2009-01-01 – 2009-12-31: -10620488 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2009-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -10620488 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10620488 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-11-000002.txt#16145 The citation records this snapshot. The page link may show a newer release later.	−USD 7.83 million Exact value Exact value: -7832332 USD 2009-01-01 – 2009-12-31: -7832332 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2009-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -7832332 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7832332 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-11-000002.txt#16593 The citation records this snapshot. The page link may show a newer release later.	USD 263,291 Exact value Exact value: 263291 USD 2009-01-01 – 2009-12-31: 263291 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2009-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 263291 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 263291 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-11-000002.txt#16639 The citation records this snapshot. The page link may show a newer release later.	−USD 8.1 million Calculation and evidence -7832332 − 263291 USD Exact free cash flow: -8095623 USD 2009-01-01 – 2009-12-31: -7832332 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 263291 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2009-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -8095623 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7832332 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-11-000002.txt#16593 Input fundies:CapitalExpenditure: 263291 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-11-000002.txt#16639 The citation records this snapshot. The page link may show a newer release later.
2010 2009-03-16 – 2010-03-15	−USD 29.89 million Exact value Exact value: -29894712 USD 2009-03-16 – 2010-03-15: -29894712 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2010-03-15 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -29894712 USD Concept: fundies:NetIncome Period: 2009-03-16 to 2010-03-15 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2010-03-15&surface=latest&period_type=duration&start=2009-03-16&unit=USD&dimensions= Input fundies:NetIncome: -29894712 USD (2009-03-16 to 2010-03-15) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#14534 The citation records this snapshot. The page link may show a newer release later.	−USD 24.3 million Exact value Exact value: -24299370 USD 2009-03-16 – 2010-03-15: -24299370 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2010-03-15 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -24299370 USD Concept: fundies:OperatingCashFlow Period: 2009-03-16 to 2010-03-15 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2010-03-15&surface=latest&period_type=duration&start=2009-03-16&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24299370 USD (2009-03-16 to 2010-03-15) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#15036 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Exact value Exact value: 1239316 USD 2009-03-16 – 2010-03-15: 1239316 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2010-03-15 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 1239316 USD Concept: fundies:CapitalExpenditure Period: 2009-03-16 to 2010-03-15 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2010-03-15&surface=latest&period_type=duration&start=2009-03-16&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1239316 USD (2009-03-16 to 2010-03-15) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#15087 The citation records this snapshot. The page link may show a newer release later.	−USD 25.54 million Calculation and evidence -24299370 − 1239316 USD Exact free cash flow: -25538686 USD 2009-03-16 – 2010-03-15: -24299370 USD · Inspect Operating Cash Flow · Source 2009-03-16 – 2010-03-15: 1239316 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2010-03-15 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -25538686 USD Concept: free-cash-flow Period: 2009-03-16 to 2010-03-15 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24299370 USD (2009-03-16 to 2010-03-15) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#15036 Input fundies:CapitalExpenditure: 1239316 USD (2009-03-16 to 2010-03-15) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/0001368993-10-000006.txt#15087 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 13.15 million Exact value Exact value: -13145078 USD 2011-01-01 – 2011-12-31: -13145078 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2011-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -13145078 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13145078 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899313000044/wgbs-20130630.xml#352790 Filing: 000136899313000044 The citation records this snapshot. The page link may show a newer release later.	−USD 16.63 million Exact value Exact value: -16626884 USD 2011-01-01 – 2011-12-31: -16626884 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2011-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -16626884 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16626884 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899313000044/wgbs-20130630.xml#386940 Filing: 000136899313000044 The citation records this snapshot. The page link may show a newer release later.	USD 621,120 Exact value Exact value: 621120 USD 2011-01-01 – 2011-12-31: 621120 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2011-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 621120 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 621120 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899313000044/wgbs-20130630.xml#387667 Filing: 000136899313000044 The citation records this snapshot. The page link may show a newer release later.	−USD 17.25 million Calculation and evidence -16626884 − 621120 USD Exact free cash flow: -17248004 USD 2011-01-01 – 2011-12-31: -16626884 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 621120 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2011-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -17248004 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16626884 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899313000044/wgbs-20130630.xml#386940 Filing: 000136899313000044 Input fundies:CapitalExpenditure: 621120 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899313000044/wgbs-20130630.xml#387667 Filing: 000136899313000044 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 8.18 million Exact value Exact value: -8176662 USD 2012-01-01 – 2012-12-31: -8176662 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2012-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -8176662 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8176662 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899314000047/wgbs-20140331.xml#327261 Filing: 000136899314000047 The citation records this snapshot. The page link may show a newer release later.	−USD 8.87 million Exact value Exact value: -8867888 USD 2012-01-01 – 2012-12-31: -8867888 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2012-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -8867888 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8867888 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899314000047/wgbs-20140331.xml#352877 Filing: 000136899314000047 The citation records this snapshot. The page link may show a newer release later.	USD 54,767 Exact value Exact value: 54767 USD 2012-01-01 – 2012-12-31: 54767 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2012-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 54767 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 54767 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899314000047/wgbs-20140331.xml#353603 Filing: 000136899314000047 The citation records this snapshot. The page link may show a newer release later.	−USD 8.92 million Calculation and evidence -8867888 − 54767 USD Exact free cash flow: -8922655 USD 2012-01-01 – 2012-12-31: -8867888 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 54767 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2012-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -8922655 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8867888 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899314000047/wgbs-20140331.xml#352877 Filing: 000136899314000047 Input fundies:CapitalExpenditure: 54767 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899314000047/wgbs-20140331.xml#353603 Filing: 000136899314000047 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 16.27 million Exact value Exact value: -16266272 USD 2013-01-01 – 2013-12-31: -16266272 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2013-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -16266272 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16266272 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899315000033/wgbs-20150630.xml#281983 Filing: 000136899315000033 The citation records this snapshot. The page link may show a newer release later.	−USD 8.22 million Exact value Exact value: -8221214 USD 2013-01-01 – 2013-12-31: -8221214 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2013-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -8221214 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8221214 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899315000033/wgbs-20150630.xml#309203 Filing: 000136899315000033 The citation records this snapshot. The page link may show a newer release later.	USD 91,545 Exact value Exact value: 91545 USD 2013-01-01 – 2013-12-31: 91545 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2013-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 91545 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 91545 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899315000033/wgbs-20150630.xml#309935 Filing: 000136899315000033 The citation records this snapshot. The page link may show a newer release later.	−USD 8.31 million Calculation and evidence -8221214 − 91545 USD Exact free cash flow: -8312759 USD 2013-01-01 – 2013-12-31: -8221214 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 91545 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2013-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -8312759 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8221214 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899315000033/wgbs-20150630.xml#309203 Filing: 000136899315000033 Input fundies:CapitalExpenditure: 91545 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899315000033/wgbs-20150630.xml#309935 Filing: 000136899315000033 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 10.69 million Exact value Exact value: -10693000 USD 2014-01-01 – 2014-12-31: -10693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2014-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -10693000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10693000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#226640 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	−USD 10.29 million Exact value Exact value: -10288000 USD 2014-01-01 – 2014-12-31: -10288000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2014-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -10288000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10288000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225604 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	USD 335,000 Exact value Exact value: 335000 USD 2014-01-01 – 2014-12-31: 335000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2014-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 335000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 335000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240438 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	−USD 10.62 million Calculation and evidence -10288000 − 335000 USD Exact free cash flow: -10623000 USD 2014-01-01 – 2014-12-31: -10288000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 335000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2014-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -10623000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10288000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225604 Filing: 000136899316000086 Input fundies:CapitalExpenditure: 335000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240438 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 15.32 million Exact value Exact value: -15315000 USD 2015-01-01 – 2015-12-31: -15315000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Net Income: -15315000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15315000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#227629 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	−USD 14.64 million Exact value Exact value: -14638000 USD 2015-01-01 – 2015-12-31: -14638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Operating Cash Flow: -14638000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14638000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225816 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	USD 308,000 Exact value Exact value: 308000 USD 2015-01-01 – 2015-12-31: 308000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Capital Expenditure: 308000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 308000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240647 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.	−USD 14.95 million Calculation and evidence -14638000 − 308000 USD Exact free cash flow: -14946000 USD 2015-01-01 – 2015-12-31: -14638000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 308000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WaferGen Bio-systems, Inc. · 2015-12-31 WaferGen Bio-systems, Inc. (edgar:1368993) Free cash flow: -14946000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:41:31Z Snapshot: 3b7bba35ee7ff145a8a1abf90ba1d1c7d541ef6c8a30b736b20bfdbf744a6338 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1368993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14638000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#225816 Filing: 000136899316000086 Input fundies:CapitalExpenditure: 308000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1368993/000136899316000086/wgbs-20151231.xml#240647 Filing: 000136899316000086 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

57 filings · 2,156 latest values · 2,154 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001368993, 1368993, edgar:1368993

Also known as La Burbuja Cafe, Inc., WaferGen Bio-systems, Inc.

WaferGen Bio-systems, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation